Detalhe da pesquisa
1.
Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen-specific T cells.
Cancer Sci
; 113(12): 4082-4091, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057084
2.
Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer.
Immunopharmacol Immunotoxicol
; 43(2): 176-182, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33541161
3.
CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine-treated ovarian cancer patients.
Cancer Sci
; 111(4): 1124-1131, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058620
4.
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients.
Cancer Immunol Immunother
; 69(10): 2001-2007, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32393999
5.
Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine.
Cancer Sci
; 108(12): 2326-2332, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28898532
6.
MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production.
Proc Natl Acad Sci U S A
; 111(26): E2676-83, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24938790
7.
Personalized peptide vaccine for cancer treatment; now and its future.
Nihon Rinsho
; 75(2): 251-256, 2017 02.
Artigo
em Japonês
| MEDLINE | ID: mdl-30562860
8.
Blockade of high mobility group box 1 augments antitumor T-cell response induced by peptide vaccination as a co-adjuvant.
Cancer Sci
; 107(12): 1721-1729, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717108
9.
Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.
Cancer Sci
; 106(9): 1111-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26122553
10.
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.
Cancer Sci
; 105(10): 1229-35, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117757
11.
A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition.
J Virol
; 87(24): 13655-64, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24109217
12.
Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.
PLoS Pathog
; 8(11): e1002997, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23144615
13.
Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth.
Med Oncol
; 39(5): 58, 2022 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150340
14.
Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
Mol Clin Oncol
; 14(2): 29, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414910
15.
Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
Biochemistry
; 49(44): 9551-62, 2010 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20886905
16.
Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
J Virol
; 83(10): 4884-94, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19279107
17.
Consistence of miniexon polymerase chain reaction-restriction fragment length polymorphism and single-copy gene sequence analyses in discriminating Leishmania genotypes.
Diagn Microbiol Infect Dis
; 57(3): 295-9, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17141456
18.
Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.
J Immunol Res
; 2017: 1423683, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536706
19.
Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination.
Oncol Lett
; 13(2): 993-999, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356990
20.
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
Int J Oncol
; 46(1): 55-62, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25310280